North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

The North America Cat Vaccine Market would witness market growth of 8.7% CAGR during the forecast period (2024-2031).

The US market dominated the North America Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $637.8 million by 2031. The Canada market is experiencing a CAGR of 11% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2024 - 2031).

The market has been experiencing significant growth, driven by many factors ranging from increasing pet ownership to advancements in veterinary medicine. As the understanding of feline health continues to expand, the importance of vaccinations in safeguarding the well-being of cats has become increasingly evident. The increasing number of households adopting cats as pets is one of the most significant factors driving the growth of the market. People are increasingly recognizing the companionship and emotional benefits pets, particularly cats, can provide. Vaccinations are essential for preventing various infectious diseases affecting cats, ensuring they lead healthy and fulfilling lives.

Greater awareness about the importance of pet vaccinations has been a driving force in encouraging more pet owners to vaccinate their cats. This heightened awareness is primarily attributable to the initiatives of veterinary organizations and pet health campaigns, which underscore the critical role of vaccinations in the prevention of diseases. These initiatives have successfully educated pet owners about the benefits of vaccinations, leading to higher vaccination rates and healthier pets.

In Mexico, the demand for cat vaccines is increasing due to heightened public health concerns and growing pet ownership. The National Institute of Statistics and Geography (INEGI) reported that pet ownership, including cats, has increased in urban areas. Public health initiatives aimed at controlling rabies, such as the annual National Vaccination Week, have been crucial in promoting the importance of pet vaccinations. These campaigns, supported by the Ministry of Health, provide free or low-cost rabies vaccinations for pets, significantly boosting vaccination rates. Hence, rising pet ownership, increasing awareness of pet health, and a focus on preventative care are expected to continue driving the regional market forward.

Free Valuable Insights: The Cat Vaccine Market is Predict to reach USD 2.5 Billion by 2031, at a CAGR of 9.2%

Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Zoetis, Inc.
• Elanco Animal Health, Inc.
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
• Virbac
• Heska Corporation (Antech Diagnostics, Inc)
• Ceva Sante Animale
• Bioveta, a.s.

North America Cat Vaccine Market Report Segmentation

By Component

• Combined Vaccines
• Mono Vaccines

By Route of Administration

• Injectables
• Intranasal
• Oral

By Duration of Immunity

• 1 Year
• 3 Year
• Others

By Disease Type

• Feline Respiratory Diseases
• Feline Rabies
• Feline Panleukopenia (Feline Distemper)
• Feline Leukemia
• Others

By Type

• Modified/Attenuated Live
• Inactivated (Killed)
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cat Vaccine Market, by Component
1.4.2 North America Cat Vaccine Market, by Route of Administration
1.4.3 North America Cat Vaccine Market, by Duration of Immunity
1.4.4 North America Cat Vaccine Market, by Disease Type
1.4.5 North America Cat Vaccine Market, by Type
1.4.6 North America Cat Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Cat Vaccine Market
Chapter 5. North America Cat Vaccine Market by Component
5.1 North America Combined Vaccines Market by Region
5.2 North America Mono Vaccines Market by Region

Chapter 6. North America Cat Vaccine Market by Route of Administration
6.1 North America Injectables Market by Country
6.2 North America Intranasal Market by Country
6.3 North America Oral Market by Country

Chapter 7. North America Cat Vaccine Market by Duration of Immunity
7.1 North America 1 Year Market by Country
7.2 North America 3 Year Market by Country
7.3 North America Others Market by Country

Chapter 8. North America Cat Vaccine Market by Disease Type
8.1 North America Feline Respiratory Diseases Market by Country
8.2 North America Feline Rabies Market by Country
8.3 North America Feline Panleukopenia (Feline Distemper) Market by Country
8.4 North America Feline Leukemia Market by Country
8.5 North America Others Market by Country

Chapter 9. North America Cat Vaccine Market by Type
9.1 North America Modified/Attenuated Live Market by Country
9.2 North America Inactivated (Killed) Market by Country
9.3 North America Others Market by Country

Chapter 10. North America Cat Vaccine Market by Country
10.1 US Cat Vaccine Market
10.1.1 US Cat Vaccine Market by Component
10.1.2 US Cat Vaccine Market by Route of Administration
10.1.3 US Cat Vaccine Market by Duration of Immunity
10.1.4 US Cat Vaccine Market by Disease Type
10.1.5 US Cat Vaccine Market by Type
10.2 Canada Cat Vaccine Market
10.2.1 Canada Cat Vaccine Market by Component
10.2.2 Canada Cat Vaccine Market by Route of Administration
10.2.3 Canada Cat Vaccine Market by Duration of Immunity
10.2.4 Canada Cat Vaccine Market by Disease Type
10.2.5 Canada Cat Vaccine Market by Type
10.3 Mexico Cat Vaccine Market
10.3.1 Mexico Cat Vaccine Market by Component
10.3.2 Mexico Cat Vaccine Market by Route of Administration
10.3.3 Mexico Cat Vaccine Market by Duration of Immunity
10.3.4 Mexico Cat Vaccine Market by Disease Type
10.3.5 Mexico Cat Vaccine Market by Type
10.4 Rest of North America Cat Vaccine Market
10.4.1 Rest of North America Cat Vaccine Market by Component
10.4.2 Rest of North America Cat Vaccine Market by Route of Administration
10.4.3 Rest of North America Cat Vaccine Market by Duration of Immunity
10.4.4 Rest of North America Cat Vaccine Market by Disease Type
10.4.5 Rest of North America Cat Vaccine Market by Type

Chapter 11. Company Profiles
11.1 Zoetis, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.5.3 Acquisition and Mergers:
11.1.6 SWOT Analysis
11.2 Elanco Animal Health, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expenses
11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Boehringer Ingelheim International GmbH
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional & Segmental Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Trials and Approvals:
11.4.6 SWOT Analysis
11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
11.5.1 Company Overview
11.5.2 SWOT Analysis
11.6 Virbac
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Recent strategies and developments:
11.6.4.1 Acquisition and Mergers:
11.6.5 SWOT Analysis
11.7 Heska Corporation (Antech Diagnostics, Inc)
11.7.1 Company Overview
11.7.2 SWOT Analysis
11.8 Ceva Sante Animale
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 Bioveta, a.s.
11.9.1 Company Overview

TABLE 1 North America Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 2 North America Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 3 North America Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 4 North America Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 5 North America Combined Vaccines Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Combined Vaccines Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Mono Vaccines Market by Region, 2020 - 2023, USD Million
TABLE 8 North America Mono Vaccines Market by Region, 2024 - 2031, USD Million
TABLE 9 North America Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 10 North America Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 11 North America Injectables Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Injectables Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Intranasal Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Intranasal Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Oral Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Oral Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 18 North America Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 19 North America 1 Year Market by Country, 2020 - 2023, USD Million
TABLE 20 North America 1 Year Market by Country, 2024 - 2031, USD Million
TABLE 21 North America 3 Year Market by Country, 2020 - 2023, USD Million
TABLE 22 North America 3 Year Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 26 North America Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 27 North America Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Feline Rabies Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Feline Rabies Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Feline Leukemia Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Feline Leukemia Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 38 North America Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 39 North America Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Cat Vaccine Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Cat Vaccine Market by Country, 2024 - 2031, USD Million
TABLE 47 US Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 48 US Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 49 US Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 50 US Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 51 US Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 52 US Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 53 US Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 54 US Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 55 US Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 56 US Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 57 US Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 58 US Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 59 Canada Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 60 Canada Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 61 Canada Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 62 Canada Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 63 Canada Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 64 Canada Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 65 Canada Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 66 Canada Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 67 Canada Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 68 Canada Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 69 Canada Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 70 Canada Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 71 Mexico Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 72 Mexico Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 73 Mexico Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 74 Mexico Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 75 Mexico Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 76 Mexico Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 77 Mexico Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 78 Mexico Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 79 Mexico Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 80 Mexico Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 81 Mexico Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 82 Mexico Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of North America Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 84 Rest of North America Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 85 Rest of North America Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 86 Rest of North America Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 87 Rest of North America Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 88 Rest of North America Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 89 Rest of North America Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 90 Rest of North America Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 91 Rest of North America Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 92 Rest of North America Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 93 Rest of North America Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 94 Rest of North America Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 95 Key Information – Zoetis, Inc.
TABLE 96 Key information – Elanco Animal Health, Inc.
TABLE 97 Key Information - Merck & Co., Inc.
TABLE 98 Key Information – Boehringer Ingelheim International GmbH
TABLE 99 Key Information – Covetrus, Inc.
TABLE 100 Key Information – Virbac
TABLE 101 Key Information – Heska Corporation
TABLE 102 Key Information – Ceva SantE Animale
TABLE 103 Key Information – Bioveta, a.s.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Cat Vaccine Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Cat Vaccine Market
FIG 4 Porter’s Five Forces Analysis – Cat Vaccine Market
FIG 5 North America Cat Vaccine Market share by Component, 2023
FIG 6 North America Cat Vaccine Market share by Component, 2031
FIG 7 North America Cat Vaccine Market by Component, 2020 - 2031, USD Million
FIG 8 North America Cat Vaccine Market share by Route of Administration, 2023
FIG 9 North America Cat Vaccine Market share by Route of Administration, 2031
FIG 10 North America Cat Vaccine Market by Route of Administration, 2020 - 2031, USD Million
FIG 11 North America Cat Vaccine Market share by Duration of Immunity, 2023
FIG 12 North America Cat Vaccine Market share by Duration of Immunity, 2031
FIG 13 North America Cat Vaccine Market by Duration of Immunity, 2020 - 2031, USD Million
FIG 14 North America Cat Vaccine Market share by Disease Type, 2023
FIG 15 North America Cat Vaccine Market share by Disease Type, 2031
FIG 16 North America Cat Vaccine Market by Disease Type, 2020 - 2031, USD Million
FIG 17 North America Cat Vaccine Market share by Type, 2023
FIG 18 North America Cat Vaccine Market share by Type, 2031
FIG 19 North America Cat Vaccine Market by Type, 2020 - 2031, USD Million
FIG 20 North America Cat Vaccine Market share by Country, 2023
FIG 21 North America Cat Vaccine Market share by Country, 2031
FIG 22 North America Cat Vaccine Market by Country, 2020 - 2031, USD Million
FIG 23 Recent strategies and developments: Zoetis, Inc.
FIG 24 Swot Analysis: ZOETIS, INC.
FIG 25 SWOT Analysis: Elanco Animal Health, Inc.
FIG 26 SWOT Analysis: Merck & Co., Inc.
FIG 27 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 28 Swot Analysis: Covetrus, Inc.
FIG 29 SWOT Analysis: Virbac
FIG 30 Swot Analysis: Heska Corporation
FIG 31 SWOT Analysis: Ceva Sante Animale